Develops targeted dry‑powder inhalation therapies and provides contract development plus GMP production services for pharmaceutical partners. Offers particle engineering (spray‑drying, high‑pressure homogenization), scalable formulations with approved/well‑tolerated excipients, in vitro/in vivo testing, preclinical studies and phase I/II clinical proof‑of‑concept.